indian pediatric hematology oncology group inphog

What indian pediatric hematology oncology group inphog does

INPHOG is India's primary collaborative clinical research network for pediatric hematology oncology, operating as a Section 8 non-profit company registered on December 22, 2021 under the Indian Companies Act. The organization coordinates multi-center clinical trials and observational studies for childhood cancers and benign hematological disorders through 27 disease-specific and transdisciplinary subcommittees, serving a nationwide network of 56 member institutions that draw on 149 participating sites. Since 2015 the network has enrolled 20,388 patients across 33 clinical trials, with 71% of the 16,335 children with cancer enrolled in observational studies and 28% in interventional studies.

The core operational "product" is the multi-center clinical trial coordination platform: INPHOG provides each member institution with a dedicated Clinical Research Coordinator (salary and benefits covered centrally) whose primary delegate must dedicate at least 80% of their time to clinical research in children with cancer. Supporting infrastructure includes a Clinical Trials Registry, annual peer-reviewed publications (2016-2023), a quarterly newsletter running since 2015 (Vol 1 Issue 1 through Vol 10 Issue 3), an Institutional Membership Program governed by application and MOU, and the annual PHOCON conference. The organization's scope expanded in 2019 when benign hematology was added and the entity was renamed from InPOG to INPHOG; three dedicated benign hematology subcommittees were activated in 2020.

INPHOG does not pursue a commercial revenue model. It is funded through voluntary donations (cheques payable to INPHOG Research Foundation) and collaborative support from partners such as Cankids KidsCan, Apar Health Services, SIOP PARC, the PHO Chapter of IAP, St. Jude Global, SIOP and the Tata Memorial Centre. The customer base is institutionally concentrated in major tertiary cancer centers (AIIMS New Delhi, Tata Memorial Centre Mumbai, Apollo Hospitals, Rajiv Gandhi Cancer Institute, Cancer Institute Chennai, PGI Chandigarh). The entity is governed by a Board of Directors chaired by Dr. Ramandeep Singh Arora with Dr. Amita Mahajan, Dr. Gauri Kapoor and Dr. Revathi Raj as Directors, supported by a strategic advisory bench drawn from St. Jude Global, SIOP, Tata Memorial and senior Indian industry figures.

Name

indian pediatric hematology oncology group inphog

Legal name

INPHOG Research Foundation

Website

https://inphog.org

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

INPHOG is a non-profit collaborative research network that coordinates multi-center pediatric hematology oncology clinical trials across 56 member institutions and 149 sites in India through 27 disease-specific subcommittees.

Ownership category

akta.pro rank

Product category

Pediatric Oncology Research

NAICS

Other Individual and Family Services (624190)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Pediatric Hematology & Oncology (HLAKAFAE)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Pediatric oncology research
• Clinical trial coordination
• Childhood cancer studies
• Multicenter clinical trials
• Hematology research network

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: INPHOG accepts voluntary donations to support its mission of improving outcomes for children with cancer through collaborative research. Donations are utilized for projects and are non-refundable once used. Cheques can be drawn in favor of INPHOG Research Foundation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

INPHOG Research Foundation coordinates a nationwide collaborative research network for pediatric hematology-oncology in India. It facilitates multicenter clinical trials and observational studies for childhood cancer and benign hematological disorders through 27 disease-specific subcommittees across 56 member institutions. The organization provides clinical research coordinator support, standardized treatment protocols, training, and data infrastructure, having enrolled over 16,335 children across 33 clinical trials since 2015.

Product overview

INPHOG Research Foundation operates as a collaborative clinical research network rather than a traditional product company. Its core offering is a multi-center clinical trial coordination platform conducted through 27 disease-specific subcommittees covering various pediatric cancers and hematological disorders. The organization facilitates clinical trials across 149+ member institutions in India, enrolling patients in observational and interventional studies. Supporting products include a clinical trials registry, annual publications, quarterly newsletters (Vol 1-10), institutional membership program, and annual PHOCON conferences. The organization focuses exclusively on advancing childhood cancer research in India through prospective collaborative studies, survivorship registries, and epidemiological surveillance.

Differentiator

Problem solved

Functional benefit

Products and services

• INPHOG Clinical Trial Coordination Platform Collaborative research platform enabling multi-center clinical trials and observational studies for childhood cancer and benign hematological disorders across 27 disease-specific subcommittees and 56 member institutions in India. Coordinates patient enrollment, protocol standardization, and data collection for prospective studies.
• Institutional Membership Program Membership program for healthcare institutions engaged in pediatric hematology-oncology research, providing access to collaborative trials, dedicated clinical research coordinator support funded by INPHOG, and training resources. Institutions apply and enter MOU agreement with INPHOG.
• Clinical Trials Registry Public registry of INPHOG clinical trials providing information on principal investigators, study protocols, and eligibility criteria for ongoing and completed multicenter studies in pediatric hematology-oncology.

Quantifiable outcome

• 16,335 children with cancer enrolled in 33 clinical trials since 2015, with 71% in observational studies and 28% in interventional studies across 149 institutions
• +1 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Cankids KidsCancoreStrategic or Co-development Partner · 1 August 2022National Society for Change for Childhood Cancer in India, working since 2004. As of August 2022, Cankids has actively partnered and funded 6 InPHOG studies (Hodgkins, HOPE, Access to care, Access India, Relapsed Hodgkin lymphoma, and Retinoblastoma) and participated in 3 other multicenter research projects. Provides financial, social and psychological support, patient navigation and education to patient families.
• Apar Health ServicescoreStrategic or Co-development Partner · 1 January 2021Healthcare skilling organization established May 2021 with vision to simplify healthcare education. Partnership formalized through MOU for Clinical Research Capacity Building. Learner-centric approach focusing on excellence, collaboration, and integrity. Dr. Pooja Sharma serves as Research Advisor and Chairperson of Research Advisory Board for INPHOG.
• ResonanceminorStrategic or Co-development Partner · 1 January 2015Healthcare organization founded in 2015 with mission to enhance healthcare outcomes through research, education, and technology. Dedicated to catalyzing positive change in oncology. Provides collaborative support to advance childhood cancer research goals.
• SIOP PARCcoreStrategic or Co-development PartnerProgramme for Advancing the Research Capacity established by SIOP Board of Directors. Focuses on pediatric cancer clinical trials in Low-Income Countries and Middle-Income Countries. Mission to enhance research capacity, advocate for evidence-based care, and mobilize resources for clinical research development in LICs and MICs.
• PHO Chapter of IAPcoreStrategic or Co-development PartnerParent organization established October 1987 with mission to enhance health and quality of life of children with blood and cancer disorders in India. Formed the Indian Pediatric Oncology Group (InPOG) in 2008 and continues as strategic partner. Biannual Scientific meetings & AGM of INPHOG held on platforms established by PHO Chapter (Mid-term CME & Annual PHOCON).
• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerDr. Carlos Rodriguez-Galindo serves as advisor, Director of St. Jude Global and Chair of Department of Global Pediatric Medicine. Led institutional effort to become first WHO Collaborating Centre for Childhood Cancer. WHO and St. Jude collaborate with INPHOG on Global Initiative in Childhood Cancer. Dr. Nickhill Bhakta from St. Jude participated in 2023 London Global Cancer Week symposium.
• Tata Memorial CentrecoreStrategic or Co-development PartnerDr. C.S. Pramesh, Director of Tata Memorial Hospital and Professor of Thoracic Surgery, serves as advisor. Convener for National Cancer Grid (170+ cancer centres in India). Key research partner with multiple INPHOG studies conducted at Tata Memorial Centre including ALL protocols.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• St. Jude Children's Research Hospital: Leading global pediatric cancer research hospital whose St. Jude Global program partners with INPHOG on the WHO Global Initiative for Childhood Cancer. St. Jude Global's Director serves on INPHOG's advisory board.
• European paediatric oncology groups (e.g., SIOP Europe / EITG): Continental European pediatric oncology research networks coordinated under SIOP Europe. Comparable multi-center trial infrastructure but focused on European populations and protocols.
• International Society of Paediatric Oncology (SIOP): Global umbrella body for pediatric oncology professionals. INPHOG is partnered with SIOP (SIOP PARC) and SIOP's president serves on INPHOG's strategic advisory board.

Direct peers

• Children's Oncology Group (COG): The world's largest pediatric cancer research organization, operating a US/North-American multi-center clinical trials network — directly analogous to INPHOG's collaborative trial network model in India.
• National Cancer Grid (India): A network of 170+ major cancer centers in India, established by Tata Memorial. Overlaps with INPHOG's institutional membership base and shares common principal investigators.
• Tata Memorial Centre: India's premier cancer hospital and research center; a key INPHOG member institution, advisor host (Dr Pramesh), and convener of the National Cancer Grid (170+ cancer centres).
• Cankids KidsCan: Indian national society for change in childhood cancer care. INPHOG's primary domestic funding and patient-support partner, having co-funded 6 INPHOG studies as of August 2022.

Emerging players

• Resonance: Healthcare research, education, and technology organization founded in 2015 that collaborates with INPHOG on advancing childhood cancer research goals in India.
• Apar Health Services: Indian healthcare skilling organization (founded May 2021) with an MOU with INPHOG for Clinical Research Capacity Building. Provides enabling education and workforce development adjacent to INPHOG's research mandate.

Regional players

• Pediatric Oncology Group of Ontario (POGO): Canadian provincial pediatric oncology research and care network. Operates a similar collaborative model for childhood cancer research but is Canada-specific rather than pan-Indian.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/INPHOG
• LinkedInlinkedin.com/company/indian-pediatric-hematology-oncology-group-inphog

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about indian pediatric hematology oncology group inphog